[HTML][HTML] The World Health Organization classification of odontogenic lesions: a summary of the changes of the 2022 (5th) edition

M Soluk-Tekkesin, JM Wright - Turkish Journal of Pathology, 2022 - ncbi.nlm.nih.gov
The 5th edition of the World Health Organization (WHO) Classification of Head and Neck
Tumors opened to online access in March 2022. This edition is conceptually similar to the …

Prevalence of oral potentially malignant disorders: a systematic review and meta‐analysis

FW Mello, AFP Miguel, KL Dutra… - Journal of Oral …, 2018 - Wiley Online Library
Oral potentially malignant disorders (OPMD) are chronic conditions, which have a higher
risk of transformation to oral squamous cell carcinoma. The aim of this systematic review and …

Update from the 5th Edition of the World Health Organization classification of head and neck tumors: odontogenic and maxillofacial bone tumours

M Vered, JM Wright - Head and neck pathology, 2022 - Springer
The 5th edition of the World Health Organization (WHO) Classification of Head and Neck
Tumours (2022) comes out only five years after the previous edition, however it presents …

Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists

JS Lewis Jr, B Beadle, JA Bishop… - … of pathology & …, 2018 - meridian.allenpress.com
Context Human papillomavirus (HPV) is a major cause of oropharyngeal squamous cell
carcinomas, and HPV (and/or surrogate marker p16) status has emerged as a prognostic …

[HTML][HTML] New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours

PM Speight, T Takata - Virchows Archiv, 2018 - Springer
The latest (4th) edition of the World Health Organization Classification of Head and Neck
tumours has recently been published with a number of significant changes across all tumour …

Ultra‐rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

S Stacchiotti, AM Frezza, JY Blay, EH Baldini… - Cancer, 2021 - Wiley Online Library
Background Among sarcomas, which are rare cancers, many types are exceedingly rare;
however, a definition of ultra‐rare cancers has not been established. The problem of ultra …

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

P Bossi, AT Chan, L Licitra, A Trama… - Annals of …, 2021 - annalsofoncology.org
Nasopharyngeal carcinoma (NPC) is a disease with unique epidemiological features. The
distribution of the disease demonstrates a clear regional, racial and gender prevalence. In …

[HTML][HTML] Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders

K Ranganathan, L Kavitha - Journal of Oral and Maxillofacial …, 2019 - journals.lww.com
After more than a decade, the World Health Organization (WHO) published the revised
grading system for oral epithelial dysplasia in 2017. The revised classification has changes …

[HTML][HTML] PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports

MJM Uijen, YHW Derks, RIJ Merkx… - European journal of …, 2021 - Springer
In the past decade, a growing body of literature has reported promising results for prostate-
specific membrane antigen (PSMA)-targeted radionuclide imaging and therapy in prostate …

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck

M Persson, Y Andrén, J Mark… - Proceedings of the …, 2009 - National Acad Sciences
The transcription factor gene MYB was identified recently as an oncogene that is
rearranged/duplicated in some human leukemias. Here we describe a new mechanism of …